Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
â‰¤ 61 62 61 62 O
2 63 64 63 64 B-upper_bound

Histological 0 12 65 77 O
confirmation 13 25 78 90 O
of 26 28 91 93 O
malignancy 29 39 94 104 B-cancer
( 40 41 105 106 O
primary 41 48 106 113 B-cancer
or 49 51 114 116 I-cancer
metastatic 52 62 117 127 I-cancer
tumor 63 68 128 133 I-cancer
) 68 69 133 134 O

Patient 0 7 135 142 O
has 8 11 143 146 O
at 12 14 147 149 O
least 15 20 150 155 O
1 21 22 156 157 B-lower_bound
site 23 27 158 162 O
of 28 30 163 165 O
measurable 31 41 166 176 O
disease 42 49 177 184 O
by 50 52 185 187 O
Response 53 61 188 196 O
Evaluation 62 72 197 207 O
Criteria 73 81 208 216 O
in 82 84 217 219 O
Solid 85 90 220 225 O
Tumors 91 97 226 232 O
( 98 99 233 234 O
RECIST 99 105 234 240 O
) 105 106 240 241 O

Patient 0 7 242 249 O
has 8 11 250 253 O
had 12 15 254 257 O
chemotherapy 16 28 258 270 B-treatment
or 29 31 271 273 O
radiotherapy 32 44 274 286 B-treatment
within 45 51 287 293 O
4 52 53 294 295 B-upper_bound
weeks 54 59 296 301 I-upper_bound
prior 60 65 302 307 I-upper_bound
to 66 68 308 310 O
entering 69 77 311 319 O
the 78 81 320 323 O
study 82 87 324 329 O

Patient 0 7 330 337 O
has 8 11 338 341 O
one 12 15 342 345 O
lesion 16 22 346 352 O
that 23 27 353 357 O
is 28 30 358 360 O
treatable 31 40 361 370 O
with 41 45 371 375 O
SBRT 46 50 376 380 B-treatment

Patient 0 7 381 388 O
is 8 10 389 391 O
a 11 12 392 393 O
pregnant 13 21 394 402 B-pregnancy
woman 22 27 403 408 B-gender
( 28 29 409 410 O
pregnant 29 37 410 418 O
women 38 43 419 424 B-gender
are 44 47 425 428 O
excluded 48 56 429 437 O
from 57 61 438 442 O
this 62 66 443 447 O
study 67 72 448 453 O
because 73 80 454 461 O
radiation 81 90 462 471 B-treatment
treatment 91 100 472 481 I-treatment
has 101 104 482 485 O
known 105 110 486 491 O
potential 111 120 492 501 O
for 121 124 502 505 O
teratogenic 125 136 506 517 O
or 137 139 518 520 O
abortifacient 140 153 521 534 O
effects 154 161 535 542 O
) 161 162 542 543 O

experimental 0 12 544 556 O
agents 13 19 557 563 O
other 20 25 564 569 O
than 26 30 570 574 O
immunotherapy 31 44 575 588 B-treatment

those 0 5 589 594 O
who 6 9 595 598 O
have 10 14 599 603 O
not 15 18 604 607 O
recovered 19 28 608 617 O
from 29 33 618 622 O
adverse 34 41 623 630 O
events 42 48 631 637 O
due 49 52 638 641 O
to 53 55 642 644 O
agents 56 62 645 651 O
administered 63 75 652 664 O
more 76 80 665 669 O
than 81 85 670 674 O
4 86 87 675 676 B-lower_bound
weeks 88 93 677 682 I-lower_bound
earlier 94 101 683 690 O

